Last C$0.54 CAD
Change Today 0.00 / 0.00%
Volume 0.0
EBN On Other Exchanges
As of 3:10 PM 08/19/14 All times are local (Market data is delayed by at least 15 minutes).

epicore bionetworks inc (EBN) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/5/14 - C$0.60
52 Week Low
09/10/13 - C$0.17
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

epicore bionetworks inc (EBN) Related Businessweek News

No Related Businessweek News Found

epicore bionetworks inc (EBN) Details

Epicore BioNetworks Inc. designs, develops, and manufactures biotechnology products and specialty animal feeds worldwide. The company offers a family of EPICIN branded biological aquaculture systems that create a cleaner and healthier growing environment in aquaculture hatcheries and grow-out ponds, as well as eliminates toxic ammonia and nitrates and improves animal health and disease resistance for the aquaculture industry. It also provides agriculture products, including EPIZYM-AW and EPIZYM-PIGS, which are animal manure bacterial inoculants to liquefy and deodorize animal waste; PHYTOZYM 2-2-2 liquid foliar spray and seed treatment, a stabilized biochemical concentrate; EPITHATCH biological thatch digester, a dry biological formulation that decomposes dead grass; and EPITHERM microbial ecosystem for composting organic waste. In addition, the company offers municipal products comprising LINEBAC, a microbial ecosystem to biodegrade contaminants in industrial and municipal wastewater collection systems; LIPOSOLVE municipal emulsifier; DEOBAC Biological deodorizer and odor neutralizer, a liquid microbial ecosystem to biodegrade organic matter; and GREASE-X aqueous cleaner and degreaser that penetrates and softens various forms of grease, fats, and oil. Further, it provides wastewater treatment products, including EPIZYM-100 microbial ecosystem for the biodegradation of industrial and municipal wastewater; and EPIZYM-200 microbial inoculant for the biodegradation of crude oil and petroleum products. Additionally, Epicore BioNetworks Inc. offers biological cleaning products, such as drain and grease trap cleaners, hard surface cleaner, carpet and upholstery shampoo, and aqueous cleaner and degreaser; and bio remediation products. The company was formerly known as Epicore Networks Inc. and changed its name to Epicore BioNetworks Inc. in 2000. Epicore BioNetworks Inc. was incorporated in 1987 and is headquartered in Eastampton, New Jersey.

Founded in 1987

epicore bionetworks inc (EBN) Top Compensated Officers

Chief Executive Officer, President, Chief Ope...
Total Annual Compensation: $229.3K
Chief Financial Officer and Company Secretary
Total Annual Compensation: $97.3K
Compensation as of Fiscal Year 2013.

epicore bionetworks inc (EBN) Key Developments

Epicore Announces Investment in Another Major Expansion to its Eastampton, NJ Facility

Epicore announced investment in another major expansion to its Eastampton, NJ facility to support its growing and profitable core aquaculture business. The company plans to build a new facility on the empty land that is adjacent to the current facility. This land was purchased in 2011 to cover just such a need. The new facility will supplement the current facility and house manufacturing and warehousing. It will eliminate the current need for outside and offsite storage and will improve the efficiency of the current operation. The additional space will facilitate maintenance of current and future quality certifications. The requisite local government approvals have been obtained for the new construction. The plan calls for a two phase approach with the first 6,000 square feet constructed in 2014 and the second 6,000 built in the future as facility needs evolve. The phase one construction costs are estimated at $0.9 million, which will be financed from Company cash and cash flow.

Epicore BioNetworks Inc. Announces Earnings Results for First Quarter Ended Mar. 31, 2014

Epicore BioNetworks Inc. announced earnings results for first quarter ended Mar. 31, 2014. For the quarter, the company reported revenue of $2,180,000, net income of $444,000 or $0.018 per share compared to the revenue of $1,516,000, net income of $59,000 or $0.002 per share for the same quarter a year ago. EBITDA increased by 176% over prior year from $0.2 million to $0.7 million.

Epicore BioNetworks Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2013

Epicore BioNetworks Inc. reported earnings results for the second quarter ended December 31, 2013. The revenue for second quarter was at $1.653 million was 25% higher than last year's second quarter of $1.321 million. Sales were broad based and not regionally limited as producers worldwide try to capitalize on record high shrimp prices. Early Mortality Syndrome (EMS) in Asia has reduced the worldwide supply of shrimp, which in turn has pushed shrimp prices to record levels. High shrimp prices have increased the demand for Epicore's productivity enhancing products. Net income was $0.320 million or $0.013 per share compared to $0.081 million or $0.003 per share a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBN:CN C$0.54 CAD 0.00

EBN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EBN.
View Industry Companies

Industry Analysis


Industry Average

Valuation EBN Industry Range
Price/Earnings 9.3x
Price/Sales 1.7x
Price/Book 1.9x
Price/Cash Flow 9.7x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPICORE BIONETWORKS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at